Alan Edrick
Analyst · ROTH Capital. Your line is open
Thank you, Deepak. Now I will review the financial results for our 2021 fiscal first quarter in greater detail. Our revenues in Q1 of fiscal 2021 were $255 million as compared to $291 million in the prior year Q1. We saw strong sales growth in the Healthcare and Opto divisions, but a sizable reduction in first quarter revenues in security. Healthcare division revenues as Deepak mentioned, increased 28% year-over-year with strength across our patient monitoring portfolio in all major geographic channels and increased sales of supplies and accessories. Opto sales rebounded significantly from pandemic-related challenges last quarter with Q1 third-party sales up 11% year-over-year, driven by strong organic growth in our contract manufacturing group as well as incremental revenues from a small acquisition completed in the second half of fiscal 2020. As expected, we saw a reduction in revenue in the Security division with sales down 29% year-over-year, largely due to the impact of the pandemic, uncertain aviation and cargo customers. Security bookings in Q1 were extremely strong, however, with a book to bill of 1.9 and significant growth in backlog. Our Q1 gross margin of 37.6% was up 350 basis points from the Q1 fiscal 2020 gross margin of 34.1% driven by margin expansion in each of our Healthcare and Security Divisions. The increase in the Healthcare gross margin was due to economies of scale associated with the revenue increase featuring strong U.S. sales, which generally carry stronger margins than international sales. In addition, our Healthcare division’s gross margin is inherently greater than our other 2 divisions, so a higher proportion of our consolidated sales in healthcare results in an overall increase in OSI is gross margin. The gross margin improvement in Security was notable given the change in sales and was driven by a favorable revenue mix and excellent operational execution. As mentioned on previous calls, our gross margin will fluctuate from period to period based on revenue, mix and volume among other factors. Moving to operating expenses, the company adjusted its cost structure towards the end of fiscal 2020 and early in fiscal 2021 in response to the pandemic. The results of these initiatives were reflected in Q1 SG&A expenses decreasing 6% year-over-year and 3% sequentially. We work diligently across each of our divisions to improve efficiencies and prudently manage our cost structure with heightened focus during these uncertain times. R&D expenses in Q1 were $12.1 million representing a year-over-year decrease of 15% and a 6% sequential decrease. We continue to dedicate considerable resources to R&D particularly in Security and Healthcare as we remain focused on innovative product development, which we view as vital to the long-term success of our business. In Q1 of fiscal 2021, we recorded an $8.4 million impairment restructuring and other charge. This charge was primarily associated with the exit of the MSET contract and other reductions in workforce to streamline our cost structure. Moving to interest and taxes, net interest and other expense in Q1 of fiscal 2021 decreased to $4.2 million from $4.7 million in the same prior year period because of reduced borrowings, given the strong cash flow and a declining interest-rate environment since last year. On the tax side, excluding the impact of discrete tax items, our effective tax rate in Q1 fiscal 2021 was 27.5% compared to 27.9% in Q1 of fiscal 2020. We recognized discrete tax benefits of $0.3 million in Q1 of fiscal 2021 compared to $6.2 million in the comparable prior year period. As a result, we reported a tax provision under GAAP of 25.3% in Q1 of fiscal 2021 compared to a tax benefit rate of negative 2.9% recorded in Q1 of fiscal 2020. Let’s now turn to a discussion of our non-GAAP adjusted operating margin, as defined in our press release. Overall, our adjusted operating margin increased from 9.1% in Q1 of fiscal 2020 to 11.3% in Q1 of fiscal 2021. We were pleased with the significant margin expansion especially in the face of overall top line headwinds. The adjusted operating margin in our Security division improved to 14.8% in the latest quarter compared to 12.2% in the prior year first quarter, driven by a favorable mix of revenues, sound operational execution, and cost control actions. Our Healthcare division reported significant operating margin expansion, more than doubling from 7% in Q1 last year to 17.8% in Q1 of fiscal 2021, driven in part by leveraging the fixed cost structure with improved sales, strong cost controls, and sound operational execution. These improvements in security and healthcare were partially offset by a reduction in the adjusted operating margin in our Opto division from 13% in Q1 of the last fiscal year to 12.1% in Q1 of fiscal 2021, primarily driven by a less favorable mix of customer revenues. Moving over to cash flow, as mentioned before, this was a very strong quarter of cash flow generation. In Q1, we produced $54 million in operating cash flow, compared with about $25 million in the same prior-year period. This was achieved despite increasing inventory as we prepare for sales growth and higher DSO due to timing of collections as certain customers stretch out payments. CapEx in the first fiscal quarter was $3.8 million, while depreciation and amortization in Q1 was $10 million. Our cash flow conversion was again exceptionally strong. We were active with our stock buyback program as part of our overall capital allocation strategy. During Q1 of fiscal 2021, we repurchased 320,000 shares under our current buyback program, leaving approximately 2.7 million shares available to repurchase under the program. Our balance sheet is strong with modest net leverage and no significant debt maturities until fiscal 2023. Finally, let’s turn to guidance. Our initial fiscal 2021 guidance range as announced in August included a modest amount of fiscal 2021 revenues in earnings associated with the potential turnkey contract in Mexico, replacing the recently expired Mexico contract. Though that contract did not materialize, we are pleased to nonetheless raise both our sales and our earnings guidance for fiscal 2021, given our first quarter results and the strength of our business and outlook for the remainder of the year. As a result, we are increasing revenue guidance to the range of $1.1 billion to $1.142 billion from $1.09 billion to $1.14 billion. Similarly, we are increasing our non-GAAP earnings per diluted share guidance to the range of $4.65 to $5.10 per share, from $4.50 to $5.05 per share. We expect to see revenue headwinds continue in the second quarter of fiscal 2021 in our Security division, stemming from the pandemic, but then believe we will build positive momentum as the year proceeds supported by the strong backlog. The non-GAAP diluted EPS range excludes potential impairment restructuring and other charges, amortization of acquired intangible assets and non-cash interest expense and their associated tax effects as well as discrete tax items. We currently believe this revenue and non-GAAP earnings guidance reflects reasonable estimates and we have included the anticipated impact of the COVID-19 pandemic in our guidance given uncertainties as to the duration and scope of the pandemic as well as other variables. However, the extent to which COVID-19 may impact the company’s financial results is difficult to predict and could vary materially from the anticipated impact currently reflected in our estimates and guidance. Actual revenues and non-GAAP earnings per diluted share could also vary from the anticipated ranges due to other risks and uncertainties discussed in our SEC filings. In the face of these challenging times, we continue to remain steadfastly focused on the growth of our business through investment in product development and strategic acquisitions, while also acutely managing our cost structure. We believe these efforts will enable OSI, to continue our leadership in providing innovative products and solutions. Finally and importantly, we would like to take this opportunity to thank the global OSI Systems team for its dedication and supporting our customers and contributing to the creation of value for our stakeholders, while maintaining a commitment to safety in the face of uncertainty. At this time, we would be happy to open the call to questions.